Acorda Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ACORQ for the last quarter is 20.29 M USD, and it's 46.59% lower compared to the previous quarter. The net income of Q1 24 is -27.39 M USD.